Vascular Grafts

Global Vascular Grafts Market to Reach US$5.9 Billion by 2030

The global market for Vascular Grafts estimated at US$3.9 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Peripheral Vascular Repair segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 8.9% CAGR

The Vascular Grafts market in the U.S. is estimated at US$1.5 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$687.6 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.5% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Vascular Grafts Market - Key Trends & Drivers Summarized

What Are Vascular Grafts, and Why Are They Critical in Modern Medicine?

Vascular grafts are medical devices used to replace, repair, or bypass sections of blood vessels in the body, often necessitated by diseases such as atherosclerosis, aneurysms, or blockages. These grafts are crucial in cardiovascular surgeries, including coronary artery bypass grafting, which helps improve blood flow to the heart. The materials used for these grafts are specifically chosen based on their compatibility with the human body and their mechanical properties, such as flexibility and durability. Vascular grafts can be made from synthetic materials like polyester and polytetrafluoroethylene (PTFE), or from biological materials, including modified human or animal tissue.

How Have Innovations Enhanced Vascular Graft Technology?

Recent innovations in vascular graft technology have significantly improved the outcomes of vascular surgeries. The development of tissue-engineering grafts, which promote cell growth and regeneration, is one example of how this field is advancing. These grafts are designed to be biocompatible and to encourage endothelialization, where new endothelial cells grow on the inner surface of the graft, thereby reducing the risk of thrombosis and ensuring the long-term patency of the graft. Additionally, advancements in imaging and diagnostic technologies have improved the precision of graft placement, minimizing risks and potential complications during surgeries. Innovations like drug-eluting grafts that help prevent infection and restenosis further enhance the efficacy and safety of vascular interventions.

What Role Do Vascular Grafts Play in Treating Vascular Diseases?

Vascular grafts play an indispensable role in the treatment of a range of vascular diseases that can lead to severe complications and even death if left untreated. In patients with coronary artery disease, vascular grafts are used to bypass clogged arteries, helping to restore normal blood flow to the heart. For individuals suffering from peripheral arterial disease, these grafts can bypass diseased arteries in the legs, alleviating symptoms like pain and cramps and preventing limb amputation. In cases of aneurysms, particularly abdominal aortic aneurysms, grafts reinforce weak arterial walls to prevent rupture. The versatility and adaptability of vascular grafts make them essential tools in vascular surgery, providing life-saving treatments for high-risk patients.

Growth in the Vascular Grafts Market Is Driven by Several Factors

The growth in the vascular grafts market is driven by several factors, including the increasing prevalence of cardiovascular diseases globally due to aging populations and rising risk factors such as diabetes, obesity, and hypertension. Technological advancements that improve graft functionality and patient compatibility also contribute to the expansion of this market. There is a growing preference for minimally invasive surgeries, which utilize smaller, more advanced grafts that reduce recovery time and improve patient outcomes. Additionally, the rise in healthcare expenditure and the availability of more sophisticated healthcare facilities in emerging economies are expanding access to vascular graft procedures. Enhanced public awareness about the benefits of early diagnosis and treatment of cardiovascular conditions further stimulates market growth, underscoring the critical nature of vascular grafts in contemporary medical practices.

SCOPE OF STUDY:

The report analyzes the Vascular Grafts market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Indication (Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair, Hemodialysis Access); Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic); End-Use (Hospitals, Ambulatory Surgical Centers)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 44 Featured) -

• Cardinal Health, Inc.
• Baxter International, Inc.
• Terumo Corporation
• Cook Medical, LLC
• Teleflex, Inc.
• LeMaitre Vascular, Inc.
• MicroPort Scientific Corporation
• iVascular S.L.U
• Jotec GmbH
• ParaGen Technologies
• sunnatech scientific corporation
• Vacis
• Cardiovascular Systems, Inc.
• Healionics
• InnAVasc Medical

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.